Programmed cell death and radioresistance

Cancer and Metastasis Reviews

Volumn 15, Issue 1, 1996, Pages 119-131

  Meyn, Raymond E ^a,b   Stephens, L Clifton ^a   Milas, Luka ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

apoptosis; murine; programmed cell death; radiation; tumor

Indexed keywords

ANIMAL CELL; APOPTOSIS; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; RADIOSENSITIVITY; REVIEW; TUMOR; TUMOR SUPPRESSOR GENE;

ANIMALS; APOPTOSIS; CELL DEATH; HUMANS; MICE; NEOPLASMS, EXPERIMENTAL; RADIATION TOLERANCE;

EID: 0029976995     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00049491     Document Type: Review

References (78)

1. Peters LJ, Brock WA, Johnson T, Meyn RE, Tofilon PJ, Milas L: Potential methods for predicting tumor radiocurability. Int J Radiat Oncol Biol Phys 12: 459-467, 1986
2. Brock WA, Geara F: Variations in human tumor and normal cell radiosensitivity: possible implications for radiotherapy. Cancer Bull 44: 117-123, 1992
3. Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, Tagle DA, Smith S, Uziel T, Sfez S, Ashkenazi M, Pecker I, Frydman M, Harnik R, Patanjali SR, Simmons A, Clines GA, Sartiel A, Gatti RA, Chessa L, Sanal O, Lavin MF, Jaspers NGJ, Taylor AMR, Arlett CF, Miki T, Weissman SM, Lovett M, Collins FS, Shiloh Y: A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268: 1749-1753, 1995
4. Hall EJ: Radiobiology for the Radiologist (4th Edition ed.). J.B. Lippincott, Philadelphia, 1994
5. Coleman CN: Beneficial liaisons: radiobiology meets cellular and molecular biology. Radiother Oncol 28: 1-15, 1993
6. Wyllie AH, Kerr JFR, Currie AR: Cell death: The significance of apoptosis. Int Rev Cytol 68: 251-306, 1980
7. Kerr JFR, Searle J: Apoptosis: Its nature and kinetic role. In: Meyn RE, Withers HR (eds) Radiation Biology in Cancer Research. Raven Press, New York, 1980, pp 367-384
8. Wyllie A: Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284: 555-556, 1980
9. Duvall E, Wyllie A: Death and the cell. Immunol Today 7: 115-119, 1986
10. Ellis R, Yuan J, Horvitz H: Mechanisms and functions of cell death. Annu Rev Cell Biol 7: 663-698, 1991
11. Steller H: Mechanisms and genes of cellular suicide. Science 267: 1445-1449, 1995
12. Kerr J, Wyllie A, Currie A: Apoptosis: A basic biological phenomenon with wide ranging implications in tissue kinetics. Br J Cancer 26: 239-257, 1972
13. Walker N, Bennett R, Kerr J: Cell death by apoptosis during involution of the lactating breast in mice and rats. Am J Anal 185: 19-32, 1989
14. Schrek R: Cinemicrographic observations and theoretical considerations on reactions of lymphocytes to X-rays. Radiology 65: 912-919, 1955
15. Cole L, Ellis M: Radiation-induced changes in tissue nucleic acids: Release of soluble deoxypolynucleotides in the spleen. Radiat Res 7: 508-517, 1957
16. Okada S: Radiation-induced death. In: Altman KI, Gerber GB, Okada S (eds) Radiation Biochemistry. Academic Press, New York, 1970, pp 247-307
17. McConkey D, Nicotera P, Hartzell P, Bellomo G, Wyllie A, Orrenius S: Glucocorticoids activate a suicide process in thymocytes through an elevation of cytosolic Ca++ concentration. Arch Biochem Biophys 269: 365-370, 1989
18. Yamada T, Ohyama H, Kinjo Y, Watanabe M: Evidence for the internucleosomal breakage of chromatin in rat thymocytes irradiated in vitro. Radiat Res 85: 544-553, 1981
19. Sellins K, Cohen J: Gene induction by γ-irradiation leads to DNA fragmentation in lymphocytes. J Immunol 139: 3199-3206, 1987
20. Yamada T, Ohyama H: Radiation-induced interphase death of rat thymocytes is internally programmed (apoptosis). Int J Radiat Biol 53: 65-75, 1988
21. Story M, Stephens L, Tomasovic S, Meyn R: A role for calcium in regulating apoptosis in rat thymocytes irradiated in vitro. Int J Radiat Biol 61: 243-251, 1992
22. Pratt N, Sodicoff M: Ultrastructural injury following X-irradiation of rat parotid gland acinar cells. Arch Oral Biol 17: 1177-1186, 1972
23. Potten C: Extreme sensitivity of some intestinal crypt cells to X and γ irradiation. Nature 269: 518-521, 1977
24. Stephens L, Schultheiss T, Ang K, Peters L: Pathogenesis of radiation injury to the salivary glands and potential methods of protection. Cancer Bull 41: 106-114, 1989
25. Stephens L, Ang K, Schultheiss T, King G, Brock W, Peters L: Target cell and mode ol radiation injury in Rhesus salivary glands. Radiother Oncol 7: 165-174, 1986
26. Stephens LC, Schultheiss TE, Price RE, Ang KK, Peters LJ: Radiation apoptosis of serous acinar cells of salivary and lacrimal glands. Cancer 67: 1539-1543, 1991
27. Gazda J, Schultheiss T, Stephens L, Ang K, Peters L: The relationship between apoptosis and atrophy in the irradiated lacrimal gland. Int J Radiat Oncol Biol Phys 24:693-697, 1992
28. Searle J, Lawson TA, Abbott PJ, Harmon B, Kerr JFR: An electron-microscope study of the mode of cell death induced by cancer chemotherapeutic agents in populations of proliferating normal and neoplastic cells. J Pathol 116: 129-138, 1975
29. Bursch W, Paffe S, Putz B, Barthel G, Schuhe-Hermann R: Determination of the length of the histological stages of apoptosis in normal liver and in altered hepatic foci or rats. Carcinogenesis 11: 847-853, 1990
30. Wyllie AH: Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overview. Cancer Metastasis Rev 11: 95-103, 1992
31. Stephens LC, Ang KK, Schultheiss TE, Milas H, Meyn RE: Apoptosis in irradiated murine tumors. Radiat Res 127: 308-316, 1991
32. Stephens LC, Hunter NR, Ang KK, Milas L, Meyn RE: Development of apoptosis in irradiated murine tumors as a function of time and dose. Radiat Res 135: 75-80, 1993
33. Meyn RE, Stephens LC, Ang KK, Hunter NR, Milas L, Peters LJ: Heterogeneity in apoptosis development in irradiated murine tumors. Int J Radiat Biol 64: 583-591, 1993
34. Meyn R, Stephens L, Hunter N, Ang K, Milas L: Reemergence of apoptotic cells between fractionated doses in irradiated murine tumors. Int J Radiat Oncol Biol Phys 30: 619-624, 1994
35. Fletcher GH: Textbook of Radiotherapy (3rd Edition ed.). Lea & Lebiger, Philadelphia, 1980
36. Dewey WC, Ling CC, Meyn RE: Radiation-induced apoptosis: Relevance to radiotherapy. Int J Radiat Oncol Biol Phys 33: 781-796, 1995.
37. Hill RP, Milas L: The proportion of stem cells in murine tumors. Int J Radiat Oncol Biol Phys 16: 513-518, 1989
38. Meyn RL, Stephens LC, Hunter NR, Milas L: Induction of apoptosis in murine tumors by cyclophosphamide. Cancer Chemother Pharmacol 33: 410-414, 1994
39. Meyn RL, Stephens LC, Hunter NR, Milas L: Kinetics of cisplatin-induced apoptosis in murine mammary and ovarian adenocarcinomas. Int J Cancer 60: 725-729, 1995
40. Meyn RE, Stephens LC, Hunter NR, Milas L: Apoptosis in murine tumors treated with chemotherapy agents. Anti-Cancer Drugs 6: 443-450, 1995
41. Wheeler J, Stephens L, Eifel P, Ang K, Milas L, Allen P, Meyn R: Apoptosis as a predictor of tumor response to radiation in stage 1B cervical adenocarcinoma. Int J Radiat Oncol Biol Phys 32: 1487-1493, 1995
42. Strasser A, Harris A, Jacks T, Cory S: DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by bcl-2. Cell 79: 324-339, 1994
43. Marin MC, Hsu B, Meyn RE, Donehower LA, El-Naggar AK, McDonnell TJ: Evidence that p53 and bcl-2 are regulators of a common cell death pathway important for in vivo lymphomagenesis. Oneogene 9: 3107-3112, 1994
44. Oltvai Z, Korsmeycr S: Checkpoints of dueling dimers foil death wishes. Cell 79: 189-192, 1994
45. Yin X-M, Oltvai ZN, Veis-Novack DJ, Linette GP, Korsmeyer SJ: Bcl-2 gene family and the regulation of programmed cell death. Cold Spring Harbor Symp Quant Biol 59: 387-393, 1994
46. LeBrun D, Warnke R, Cleary M: Expression of bcl-2 in fetal tissues suggests a role in morphogenesis. Am J Pathol 142: 743-753, 1993
47. Tsujimoto Y, Cossman E, Jaffe H, Croce C: Involvement of the bcl-2 gene in human follicular lymphoma. Science 228: 1440-1443, 1985
48. McDonnell T, Troncosco P, Brisbay S, Logothetis C, Chung L, Hsieh J, Tu S, Campbell M: Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res 52: 6940-6944, 1992
49. Bhargava V, Kell D, van de Rijn M, Warnke R: Bcl-2 immunoreactivity in breast carcinoma correlates with hormone receptor positivity. Am J Pathol 145: 535-540, 1994
50. Reed J, Meister L, Tanaka S, Cuddy M, Yum S, Geyer C, Pleasure D: Differential expression of bcl-2 protooncogene in neuroblastoma and other human tumor cell lines of neural origin. Cancer Res 51: 6529-6538, 1991
51. Hockenbery D, Nunez G, Milliman C, Schreiber R, Korsmeyer S: Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348: 334-336, 1990
52. Jacobson M, Burne J, Raff M: Programmed cell death and bcl-2 protection in the absence of a nucleus. EMBO J 13: 1899-1910, 1994
53. 2+ fluxes. Proc Natl Acad Sci USA 91: 6569-6573, 1994
54. Nicotera P, Bellomo G, Orrenius S: Calcium-mediated mechanisms in chemically induced cell death. Annu Rev Pharmacol Toxicol 32: 449-470, 1992
55. Hockenbery D, Oltvai Z, Yin X-M, Milliman C, Korsmeyer S: Bcl-2 functions in an antioxident pathway to prevent apoptosis. Cell 75: 241-251, 1993
56. Kane D, Sarafin T, Auton S, Hahn H, Gralla F, Valentine J, Ord T, Bredesen D: Bcl-2 inhibition of neural cell death: decreased generation of reactive oxygen species. Science 262: 1274-1276, 1993
57. Albrecht H, Tschopp J, Jongencel CV: Bcl-2 protects from oxidative damage and apoptotic cell death without interfering with activation of NF-kB by TNF. FEBS Lett 351: 45-48, 1994
58. Sandstrom P, Mannie M, Buttke T: Inhibition of activation-induced death in T cell hybridomas by thiol antioxidants: Oxidative stress as a mediator of apoptosis. J Leukoc Biol 55: 221-226, 1994
59. 2+: Their relationship to apoptosis and ontogenesis. FEBS Lett 325: 104-1117, 1993
60. Sarin A, Clerici M, Blatt S, Hendrix C, Shearer G, Henkart P: Inhibition of activation-induced programmed cell death and restoration of defective immune responses of HIV donors by cysteine protease inhibitors. J Immunol 153: 862-872, 1994
61. Wang H-G, Miyashita T, Takayama S, Sato T, Torigoe T, Krajewski S, Tanaka S, Hovey III L, Troppmair J, Kapp U, Reed J: Apoptosis regulation by interaction of Bcl-2 protein and Raf-1 kinase. Oncogene 9: 2751-2756, 1994
62. Story M, Vochringer D, Malone C, Hobbs M, Meyn R: Radiation-induced apoptosis m sensitive and resistant cells isolated from a mouse lymphoma. Int J Radiat Biol 66: 659-668, 1994
63. Lu X, Lane D: Differential induction of transcriptionally active p53 following UV or ionizing radiation: defects in chromosome instability syndromes? Cell 75: 765-778, 1993
64. Kastan M, Onyekwere O, Sidransky D, Vogelslein B, Craig R: Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51: 6304-6311, 1991
65. Kastan MB, Canman CE, Leonard CJ: P53, cell cycle control and apoptosis: Implications for cancer. Cancer Metastasis Rev 14: 3-15, 1995
66. Kuerbitz S, Plunkett B, Walsh W, Kastan M: Wild-type p53 is a cell cycle checkpoint determinant following radiation. Nature (London) S9: 7491-7495, 1992
67. Canman CE, Gilmer TM, Coutts SB, Kastan MB: Growth factor modulation of p53-mediated growth arrest versus apoptosis. Genes Dev 9: 600-611, 1995
68. Lowe S, Schmitt H, Smith S, Osborne B, Jacks T: p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature (London) 362: 847-849, 1993
69. Clarke A, Purdie C, Harrison D, Morris R, Bird C, Hooper M, Wyllie A: Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature (London) 362: 849-852, 1993
70. Lane D: p53, guardian of the genome. Nature (London) 358: 15-16, 1992
71. Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A, Oren M: Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature (London) 352: 345-347, 1991
72. Shaw P, Bovey R, Tardy S, Sahli R, Sordat B, Costa J: Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc Natl Acad Sci USA 89: 4495-4499, 1992
73. Selvakumaran M, Lin H-K, Miyashita T, Wang H, Krajewski S, Reed J, Hoffman B, Liebermann D: Immediate early up-regulation of bax expression by p53 but not TFGβ1: a paradigm for distinct apoptotic pathways. Oncogene 9: 1791-1798, 1994
74. Lowe S, Ruley H: Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis. Genes Dev 7: 535-545, 1993
75. Chiou S-K, Tseng C-C, Rao L, White E: Functional complementation of the adenovirus E1B 19-kilodalton protein with bcl-2 in the inhibition of apoptosis in infected cells. J Virol 68: 6553-6566, 1994
76. Wu X, Levine A: p53 and E2F-1 cooperate to mediate apoptosis. Proc Natl Acad Sci USA 91: 3602-3606, 1994
77. Lowe S, Jacks T, Housman D, Ruley H: Abrogation of oncogene-associated apoptosis allows transformation of p53-deficient cells. Proc Natl Acad Sci USA 91: 2026-2030, 1994
78. Lowe SW, Bodis S, McClatchey A, Remington L, Ruley HE, Fisher DE, Housman DE, Jacks T: p53 status and the efficacy of cancer therapy in vivo. Science 266: 807-810, 1994